CCB International Raises WUXI XDC (02268) Target Price to HK$90, Keeps "Outperform" Rating

Stock News

2025/11/20

CCB International has raised its target price for WUXI XDC (02268) from HK$72 to HK$90, a 25% increase, while maintaining an "Outperform" investment rating. The firm highlights WUXI XDC as a global leader in ADC/XDC R&D outsourcing, benefiting from low competition and high barriers to entry.

The company's client base expanded from 345 in 2023 to 499 in 2024, reaching 563 in the first half of 2025. Order growth remains robust, with H1 2025 orders surging 58% YoY to $1.3 billion (2024: +71% YoY). WUXI XDC has also outlined new capacity expansion plans, with total capital expenditure of RMB7 billion planned from 2026 to 2029 to meet rising ADC/XDC demand.

CCB International maintains its 2025 revenue growth forecast at 45% YoY (H1 2025: +62% YoY), aligning with market expectations. Profit projections for 2025–2027 and full-year 2025 capex estimates (RMB1.56 billion) remain unchanged, including RMB900 million and RMB450 million allocated for Singapore and Wuxi facilities, respectively. The firm expects positive free cash flow of RMB555 million by end-2026.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1150143509"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1150143509\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1150143509?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-20 10:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150143509","market":"us","top_or_hot":-1,"title":"CCB International Raises WUXI XDC (02268) Target Price to HK$90, Keeps \"Outperform\" Rating","media":"Stock News","content":"<p>CCB International has raised its target price for WUXI XDC (02268) from HK$72 to HK$90, a 25% increase, while maintaining an \"Outperform\" investment rating. The firm highlights WUXI XDC as a global leader in ADC/XDC R&D outsourcing, benefiting from low competition and high barriers to entry.</p>\n<p>The company's client base expanded from 345 in 2023 to 499 in 2024, reaching 563 in the first half of 2025. Order growth remains robust, with H1 2025 orders surging 58% YoY to $1.3 billion (2024: +71% YoY). WUXI XDC has also outlined new capacity expansion plans, with total capital expenditure of RMB7 billion planned from 2026 to 2029 to meet rising ADC/XDC demand.</p>\n<p>CCB International maintains its 2025 revenue growth forecast at 45% YoY (H1 2025: +62% YoY), aligning with market expectations. Profit projections for 2025–2027 and full-year 2025 capex estimates (RMB1.56 billion) remain unchanged, including RMB900 million and RMB450 million allocated for Singapore and Wuxi facilities, respectively. The firm expects positive free cash flow of RMB555 million by end-2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CCB International Raises WUXI XDC (02268) Target Price to HK$90, Keeps \"Outperform\" Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCCB International Raises WUXI XDC (02268) Target Price to HK$90, Keeps \"Outperform\" Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-11-20 10:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CCB International has raised its target price for WUXI XDC (02268) from HK$72 to HK$90, a 25% increase, while maintaining an \"Outperform\" investment rating. The firm highlights WUXI XDC as a global leader in ADC/XDC R&D outsourcing, benefiting from low competition and high barriers to entry.</p>\n<p>The company's client base expanded from 345 in 2023 to 499 in 2024, reaching 563 in the first half of 2025. Order growth remains robust, with H1 2025 orders surging 58% YoY to $1.3 billion (2024: +71% YoY). WUXI XDC has also outlined new capacity expansion plans, with total capital expenditure of RMB7 billion planned from 2026 to 2029 to meet rising ADC/XDC demand.</p>\n<p>CCB International maintains its 2025 revenue growth forecast at 45% YoY (H1 2025: +62% YoY), aligning with market expectations. Profit projections for 2025–2027 and full-year 2025 capex estimates (RMB1.56 billion) remain unchanged, including RMB900 million and RMB450 million allocated for Singapore and Wuxi facilities, respectively. The firm expects positive free cash flow of RMB555 million by end-2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2488822045.USD","symbol_name":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","start_time":0,"source_url":"","article_id":"1150143509","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150143509","pubTimestamp":1763605583,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"CCB International has raised its target price for WUXI XDC (02268) from HK$72 to HK$90, a 25% increase, while maintaining an \"Outperform\" investment rating. The firm highlights WUXI XDC as a global...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","02268":"药明合联","BK1141":"生命科学工具和服务","SG9999014674.SGD":"Nikko AM All China Equity A SGD"},"translate_title":"建银国际上调无锡新地(02268)目标价至90港元维持“跑赢大市”评级","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02268":1},"content_text":"CCB International has raised its target price for WUXI XDC (02268) from HK$72 to HK$90, a 25% increase, while maintaining an \"Outperform\" investment rating. The firm highlights WUXI XDC as a global leader in ADC/XDC R&D outsourcing, benefiting from low competition and high barriers to entry.\nThe company's client base expanded from 345 in 2023 to 499 in 2024, reaching 563 in the first half of 2025. Order growth remains robust, with H1 2025 orders surging 58% YoY to $1.3 billion (2024: +71% YoY). WUXI XDC has also outlined new capacity expansion plans, with total capital expenditure of RMB7 billion planned from 2026 to 2029 to meet rising ADC/XDC demand.\nCCB International maintains its 2025 revenue growth forecast at 45% YoY (H1 2025: +62% YoY), aligning with market expectations. Profit projections for 2025–2027 and full-year 2025 capex estimates (RMB1.56 billion) remain unchanged, including RMB900 million and RMB450 million allocated for Singapore and Wuxi facilities, respectively. The firm expects positive free cash flow of RMB555 million by end-2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}